Top Biotechnology companies in United States by Total Assets

This ranking features the top 509 Biotechnology companies in United States ranked by Total Assets, totaling a Total Assets of USD 1.55 T, for June 27, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue EBIT EBITDA Net Income Free Cash Flow Dividend Yield Free Cash Flow Yield Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

1 2 3 4 … 11

Frequently Asked Questions

Which Biotechnology company in United States has the highest Total Assets ?

The Biotechnology company in United States with the highest Total Assets is Pfizer Inc. (NYSE: PFE) at USD 213.40 B.
Which Biotechnology company in United States has the lowest Total Assets ?

The Biotechnology company in United States with the lowest Total Assets is Alto Neuroscience, Inc. (NYSE: ANRO) at None.

What are the top 10 Biotechnology companies in United States by Total Assets ?

The top 10 Biotechnology companies in United States by Total Assets are Pfizer Inc., AbbVie Inc., Merck & Co., Inc., Thermo Fisher Scientific Inc., Bristol-Myers Squibb Company, Amgen Inc., Abbott Laboratories, Danaher Corporation, Gilead Sciences, Inc. and Becton, Dickinson and Company.
What are the bottom 10 Biotechnology companies in United States by Total Assets ?

The bottom 10 Biotechnology companies in United States by Total Assets are Alto Neuroscience, Inc., Annexon, Inc., Anebulo Pharmaceuticals, Inc., Autonomix Medical, Inc. Common Stock, Alzamend Neuro, Inc., Anixa Biosciences, Inc., Aclaris Therapeutics, Inc., Actuate Therapeutics Inc, Aclarion, Inc. and AN2 Therapeutics, Inc..